+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nebulizer Market - Forecasts from 2019 to 2024

  • PDF Icon

    Report

  • 112 Pages
  • October 2019
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 4858343
The nebulizer market is expected to reach $1,435.016 million by 2024 from $736.046 million in 2018 growing at a CAGR of 11.77%. Nebulizer is a device that changes the medication from liquid into the mist form which can be easily inhaled into the lungs. When inhaled, the medication reaches even the smaller airways and works more effectively. The devices are preferred choice when delivering medications to infants, small children or to the patient who has difficulty using inhalers. Nebulization is used for both - immediate relief as well as maintenance therapy for various respiratory disorders. The market is expected to show robust growth during the given forecast period. The growth in the market may be attributed to the rising prevalence of respiratory diseases across the globe. WHO reports a prevalence of 251 million cases of COPD globally in 2016 with 3.17 million deaths due to COPD in 2015. Rising adoption and preference of the homecare products for the treatment and management of respiratory diseases will further augment the market for nebulizers. However, wastage of the medication during the drug delivery using nebulizer might restrict the growth of the market during the given time frame.

The Nebulizer Market - Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, polarization, voltage, and geography.

The nebulizer market has been segmented based on type, indication, end-user, and geography. Based on type, the market has been segmented into jet nebulizer, ultrasonic nebulizer, mesh nebulizer. By indication, asthma, chronic obstructive pulmonary disease, bronchitis, and others. The research study is also evaluated on the basis of end-user such as hospitals and clinics, ambulatory care centers, and home care settings.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the nebulizer market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the nebulizer market.

Segmentation

The nebulizer market has been analyzed through following segments:

By Type
  • Jet Nebulizer
  • Ultrasonic Nebulizer
  • Mesh Nebulizer

By Indication
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Bronchitis
  • Others

By End-User
  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Homecare Settings

By Geography

North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NEBULIZER MARKET BY TYPE
5.1. Jet Nebulizer
5.2. Ultrasonic Nebulizer
5.3. Mesh Nebulizer
6. NEBULIZER MARKET BY INDICATION
6.1. Asthma
6.2. Chronic Obstructive Pulmonary Disease
6.3. Bronchitis
6.4. Others
7. NEBULIZER MARKET BY END-USER
7.1. Hospitals and Clinics
7.2. Ambulatory Care Centers
7.3. Homecare Settings
8. NEBULIZER MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. South Korea
8.5.4. India
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Beurer
10.2. Pari Respiratory Equipment, Inc.
10.3. OMRON Healthcare, Inc.
10.4. Koninklijke Philips N.V.
10.5. Rotech Healthcare, Inc.
10.6. PerkinElmer, Inc.
10.7. Becton, Dickinson, and Company
10.8. Heyer Medical AG
10.9. GE Healthcare
10.10. Aerogen

Companies Mentioned

  • Beurer
  • Pari Respiratory Equipment, Inc.
  • OMRON Healthcare, Inc.
  • Koninklijke Philips N.V.
  • Rotech Healthcare, Inc.
  • PerkinElmer, Inc.
  • Becton, Dickinson, and Company
  • Heyer Medical AG
  • GE Healthcare
  • Aerogen